by Spatial omics technologies allow characterization of biological molecules in their native spatial context with high sensitivity and resolution. Spatial omics solutions enable spatial mapping of RNA transcripts, proteins and other biomolecules in tissues and cells at single-cell resolution. This provides insights into complex biological processes at a deeply localized level.
The global Spatial Omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of spatial omics approaches in drug discovery and precision medicine has been a major driver of growth in the spatial omics market. By mapping complex biological processes at micro and nanoscale levels within tissues, spatial omics tools help gain a deeper understanding of disease heterogeneity and responses to therapies at localized cellular scales. This high resolution precision mapping of cellular spaces has significant potential to accelerate development of more effective targeted therapies and personalized treatment regimens.
SWOT Analysis
Strengths: The spatial omics market utilizes advanced technologies such as spatial genomic techniques to identify disease risk factors at cellular and tissue level with high accuracy.
Weaknesses: High capital requirement for establishment of spatial omics infrastructure and skilled workforce shortage are some bottlenecks.
Opportunities: Rising R&D investments in biopharmaceutical industry and growing application areas in cancer diagnosis offer lucrative growth opportunities.
Threats: Stringent regulatory landscape and ethical issues associated with genomic tests pose significant challenges.
Key Takeaways
The Global Spatial Omics Market is expected to witness high growth over the forecast period supported by ongoing technological advancements. The global Spatial Omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030.
North America captured over 40% share of the global market in 2023 owing to strong foothold of leading players and sizeable investments in precision medicine research.
Key players operating in the spatial omics market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. The extensive proteomic and genomic profiling solutions offered by these players have accelerated spatial analysis adoption across major end-use industries. Spatial omics enables in-depth investigation of tissue microenvironments at single-cell resolution, thereby facilitating improved understanding of disease pathologies and identification of novel drug targets.
Note:
Source: Coherent Market Insights, Public sources, Desk research
We have leveraged AI tools to mine information and compile it
